Literature DB >> 16041915

The management of fatigue in depressed patients.

Humberto Marin1, Matthew A Menza.   

Abstract

Three quarters of patients who respond to treatment with the newer antidepressants still complain of fatigue. Fatigue is one of the most common and disturbing residual symptoms of depression. Increased serotonin activity in certain areas of the brain contributes to fatigue. It can be counteracted by dopaminergic agents which, interestingly, are enhanced by exercise. Specific steps that can be used to address residual fatigue include cognitive interventions based on those used to address somatoform disorders; graded aerobic exercise; dose reduction or discontinuation of fatigue-inducing antidepressants; and the prescription of such medications as dopaminergic antidepressants (bupropion), stimulants, thyroid preparations, and modafinil.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041915

Source DB:  PubMed          Journal:  Essent Psychopharmacol        ISSN: 1087-495X


  8 in total

1.  Patterns and predictors of depression treatment among adults with chronic kidney disease and depression in ambulatory care settings in the United States.

Authors:  Nina Vadiei; Sandipan Bhattacharjee
Journal:  Int Urol Nephrol       Date:  2018-12-04       Impact factor: 2.370

Review 2.  Exercising our brains: how physical activity impacts synaptic plasticity in the dentate gyrus.

Authors:  Brian R Christie; Brennan D Eadie; Timal S Kannangara; Julie M Robillard; James Shin; Andrea K Titterness
Journal:  Neuromolecular Med       Date:  2008-06-06       Impact factor: 3.843

Review 3.  Sleep disturbances and fatigue in critically ill patients.

Authors:  Ellyn E Matthews
Journal:  AACN Adv Crit Care       Date:  2011 Jul-Sep

4.  Cultural adaptation and validation of the Chinese version of the Fatigue Severity Scale in patients with major depressive disorder and nondepressive people.

Authors:  Mei-Yeh Wang; I-Chao Liu; Chen-Huan Chiu; Pei-Shan Tsai
Journal:  Qual Life Res       Date:  2015-06-27       Impact factor: 4.147

Review 5.  Adjunctive use of modafinil in bipolar patients: just another stimulant or not?

Authors:  Richard C Shelton; Rakesh Reddy
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

6.  The importance of norepinephrine in depression.

Authors:  Chantal Moret; Mike Briley
Journal:  Neuropsychiatr Dis Treat       Date:  2011-05-31       Impact factor: 2.570

Review 7.  Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  BMC Med       Date:  2015-02-06       Impact factor: 8.775

Review 8.  Evidence-based kernels: fundamental units of behavioral influence.

Authors:  Dennis D Embry; Anthony Biglan
Journal:  Clin Child Fam Psychol Rev       Date:  2008-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.